NM_000209.4:c.719C>G
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 1P and 1B. PP2BP4
The NM_000209.4(PDX1):c.719C>G(p.Pro240Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000726 in 1,515,730 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P240S) has been classified as Uncertain significance.
Frequency
Consequence
NM_000209.4 missense
Scores
Clinical Significance
Conservation
Publications
- maturity-onset diabetes of the young type 4Inheritance: AR, AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- pancreatic agenesis 1Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: ClinGen, Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- permanent neonatal diabetes mellitusInheritance: AR, AD Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
- monogenic diabetesInheritance: AD Classification: MODERATE Submitted by: ClinGen
- maturity-onset diabetes of the youngInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- pancreatic agenesisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152066Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000259 AC: 3AN: 116046 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000733 AC: 10AN: 1363664Hom.: 0 Cov.: 31 AF XY: 0.00000149 AC XY: 1AN XY: 671874 show subpopulations
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152066Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74268 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
- -
PDX1-related disorder Uncertain:1
The PDX1 c.719C>G variant is predicted to result in the amino acid substitution p.Pro240Arg. This variant was reported in an individual with type 1 diabetes (Supplemental Table 7, Yu et al 2019. PubMed ID: 31264968). This variant is reported in 0.0063% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/13-28498705-C-G). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Type 2 diabetes mellitus;C1833382:Maturity-onset diabetes of the young type 4;C3891828:Pancreatic agenesis 1 Uncertain:1
- -
Monogenic diabetes Uncertain:1
ACMG criteria: PP3 (3 predictors), BP4 (8 predictors), PM2 (absent in database), NOTE: Athena calls VUS=VUS -
not provided Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 447926). This missense change has been observed in individual(s) with type 1 diabetes (PMID: 31264968). This variant is present in population databases (no rsID available, gnomAD 0.006%). This sequence change replaces proline, which is neutral and non-polar, with arginine, which is basic and polar, at codon 240 of the PDX1 protein (p.Pro240Arg). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at